Amp Capital Investors LTD Regeneron Pharmaceuticals, Inc. Transaction History

Amp Capital Investors LTD

$0
Q4 2022

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $24.4 Million - $30.2 Million	-44,948 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $640,043 - $759,270	-1,115 Reduced 2.42%	44,948 $27.2 Million
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $735,676 - $869,088	-1,556 Reduced 3.27%	46,063 $25.7 Million
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $2.56 Million - $3.14 Million	5,721 Added 13.65%	47,619 $22.5 Million
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $1.48 Million - $1.88 Million	-3,100 Reduced 6.89%	41,898 $20 Million
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $638,991 - $772,080	1,173 Added 2.68%	44,998 $25.8 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $109,023 - $142,306	221 Added 0.51%	43,825 $26.8 Million
Q1 2020 May 13, 2020	BUY	$336.18 - $494.43 $1.85 Million - $2.72 Million	5,500 Added 14.43%	43,604 $20.6 Million
Q4 2019 Feb 13, 2020	BUY	$274.13 - $376.51 $1.75 Million - $2.41 Million	6,395 Added 20.17%	38,104 $14.2 Million
Q3 2019 Nov 13, 2019	SELL	$273.46 - $318.39 $3.27 Million - $3.81 Million	-11,967 Reduced 27.4%	31,709 $8.67 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $5.61 Million - $7.77 Million	18,731 Added 75.09%	43,676 $13.6 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $1.41 Million - $1.67 Million	3,799 Added 17.97%	24,945 $10.1 Million
Q4 2018 Feb 13, 2019	SELL	$335.82 - $403.04 $1.29 Million - $1.55 Million	-3,848 Reduced 15.4%	21,146 $7.67 Million
Q3 2018 Nov 13, 2018	SELL	$351.14 - $408.51 $1.09 Million - $1.27 Million	-3,101 Reduced 11.04%	24,994 $10.1 Million
Q2 2018 Aug 13, 2018	SELL	$284.6 - $344.99 $3.59 Million - $4.36 Million	-12,627 Reduced 31.01%	28,095 $9.69 Million
Q1 2018 May 15, 2018	BUY	$315.82 - $393.78 $2.51 Million - $3.13 Million	7,949 Added 24.25%	40,722 $13.8 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $724,432 - $949,299	2,020 Added 6.57%	32,773 $12.3 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $3.66 Million - $4.28 Million	8,487 Added 38.12%	30,753 $13.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	22,266	22,266 $11.4 Million

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

News

Stay updated on Amp Capital Investors LTD with notifications on news.

Account